Therapeutic drug monitoring of imatinib - how far are we in the leukemia setting? - Buhl Rasmussen AS; Andersen CL; Weimann A; Yang T; Tron C; Gandemer V; Dalhoff K; Rank CU; Schmiegelow K (Expert review of clinical pharmacology, 2024)